Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Multiple sclerosis: immunochemical studies on the demyelinating serum factor.

I Grundke-Iqbal, M B Bornstein

    Brain Research
    |January 19, 1979
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Presence and action of acetylcholine in experimental brain trauma.

    Journal of neurophysiology·2010
    Same author

    Tau in Alzheimer disease and related tauopathies.

    Current Alzheimer research·2010
    Same author

    An electron microscopic study of the development of synapses in cultured fetal mouse cerebrum continuously exposed to xylocaine.

    The Journal of cell biology·2009
    Same author

    Alzheimer neurofibrillary degeneration: significance, etiopathogenesis, therapeutics and prevention.

    Journal of cellular and molecular medicine·2008
    Same author

    Developing pharmacological therapies for Alzheimer disease.

    Cellular and molecular life sciences : CMLS·2007
    Same author

    Biological markers in Alzheimer's disease.

    Bratislavske lekarske listy·2007
    Same journal

    IGFBP3 and UBE2C are associated with protein modification pathways and serve as prognostic markers in glioma.

    Brain research·2026
    Same journal

    Targeting neurodevelopmental miR132-3p promotes neuroprotection and axon regeneration after optic nerve injury in mice.

    Brain research·2026
    Same journal

    Variability in acoustic startle response and prepulse inhibition across adulthood in Fragile X messenger ribonucleoprotein 1 knockout mice.

    Brain research·2026
    Same journal

    Transcriptome-guided modeling reveals insulin-related metabolic dysfunction in SCA3 mouse cerebellum.

    Brain research·2026
    Same journal

    Intranasal stromal cell-derived factor-1α mitigates parkinsonian deficits via dual modulation of neuroinflammation and gut microbiota in MPTP-induced models.

    Brain research·2026
    Same journal

    Emotions, the amygdala, and the right hemisphere.

    Brain research·2026
    See all related articles

    Multiple sclerosis (MS) patient sera contain demyelinating factors. Research suggests immunoglobulin G3 (IgG3) is the likely culprit, as other IgG types were removed without eliminating this activity.

    Area of Science:

    • Neuroimmunology
    • Biochemistry

    Background:

    • Multiple sclerosis (MS) is characterized by central nervous system demyelination.
    • Factors in MS patient sera contribute to demyelination in vitro.
    • Previous studies implicated immunoglobulin G (IgG) fractions in demyelinating activity.

    Purpose of the Study:

    • To investigate the specific immunoglobulin G (IgG) subclass responsible for demyelinating activity in multiple sclerosis (MS) sera.
    • To determine if IgG1, IgG2, or IgG4 are the primary demyelinating agents in MS.

    Main Methods:

    • Isolation of IgG from MS patient sera using staphylococcal protein A, which binds IgG1, IgG2, and IgG4.
    • Treatment of central nervous system tissue cultures with isolated IgG fractions and human complement.
    • Assessment of demyelinating activity in treated tissue cultures.

    Related Experiment Videos

    Main Results:

    • Isolated IgG fractions from MS sera actively demyelinated central nervous system tissue cultures in the presence of complement.
    • Absorption with protein A, which removes IgG1, IgG2, and IgG4, did not fully eliminate demyelinating activity.
    • A significant portion of the demyelinating activity remained after removing IgG1, IgG2, and IgG4.

    Conclusions:

    • The majority of demyelinating activity in MS sera is not associated with IgG1, IgG2, or IgG4.
    • Immunoglobulin G3 (IgG3) is the most probable active factor responsible for demyelination in MS sera.
    • Further research is warranted to confirm IgG3 as the primary demyelinating agent in MS.